Biohaven Pharmaceutical Holding Company Ltd

NYSE:BHVN   12:07:41 PM EDT
+0.02 (+0.01%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.58B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$247.59 Million
Adjusted EPS-$2.18
See more estimates
10-Day MA$147.38
50-Day MA$145.66
200-Day MA$128.58
See more pivots

Biohaven Pharmaceutical Holding Company Ltd Stock, NYSE:BHVN

215 Church Street, New Haven, Connecticut 06510-1803
Virgin Islands, British
Phone: +1.203.404.0410
Number of Employees: 928


Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.